<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01963442</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-12-202.0496 - PTC</org_study_id>
    <secondary_id>2013-000265-36</secondary_id>
    <nct_id>NCT01963442</nct_id>
  </id_info>
  <brief_title>Short Duration Treatment of Non-severe Community Acquired Pneumonia</brief_title>
  <acronym>PTC</acronym>
  <official_title>A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when
      compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of
      treatment in terms of clinical efficacy, in adults admitted to emergency services for a non
      severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin
      treatment (3GC or A/AC).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical evaluation at Day 15</measure>
    <time_frame>Day 15</time_frame>
    <description>Clinical evaluation at Day 15 composed of the composite measure of the Clinical examination for clinical symptoms of CAP, recording of the body temperature and confirmation that no additionnal antibiotic treatment was required from Day 8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical evaluation at Day 30</measure>
    <time_frame>Day 30</time_frame>
    <description>Clinical evaluation at Day 30 composed of the composite measure of the Clinical examination for clinical symptoms of CAP, recording of the body temperature and Evaluation of replapse or aggravation of pneumonia or any other respiratory infections in subjects considered cured at Day 15.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>mortality all causes at Day 30</measure>
    <time_frame>Day 30</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">310</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Amoxicillin/Clavulanic acid treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after 3 day treatment of β-lactams, the subjects receive 5-day treatment of Amoxicillin/clavulanic acid. Chest X-ray performed at admission and Day 30 and replapses. 'blood sampling /Cell Counts/CRP/Biochemistry' performed at Day 0, Day 30 and relapse</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>after 3-day treatment of β-lactams, the subjects receive 5-day treatment of placebo. Chest X-ray performed at admission and Day 30 and replapse. blood sampling /Cell Counts/CRP/Biochemistry' performed at Day 0, Day 30 and relapse</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Chest X-ray</intervention_name>
    <description>at Day 0, Day 30 and relapse</description>
    <arm_group_label>Amoxicillin/Clavulanic acid treatment</arm_group_label>
    <arm_group_label>placebo treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling /Cell Counts/ C reactive protein (CRP)/Biochemistry</intervention_name>
    <arm_group_label>Amoxicillin/Clavulanic acid treatment</arm_group_label>
    <arm_group_label>placebo treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Augmentin</intervention_name>
    <description>2 tablets 3 times a day for 5 days from Day 3</description>
    <arm_group_label>Amoxicillin/Clavulanic acid treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Augmentin)</intervention_name>
    <description>2 tablets 3 times a day for 5 days from Day 3</description>
    <arm_group_label>placebo treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Beta-Lactams</intervention_name>
    <description>administered from Day 0 to Day 3</description>
    <arm_group_label>Amoxicillin/Clavulanic acid treatment</arm_group_label>
    <arm_group_label>placebo treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be 18 years old or over.

          -  admitted three days before for Community Acquired Pneumonia (CAP) defined by at least
             one clinical sign of pneumonia (dyspnea, cough, mucopurulent sputum, crackling sound
             on lungs) associated with a temperature &gt;38°C on admission, and a new infiltrate
             consistent with pneumonia on chest x-ray, who responded favorably to 3 days of
             treatment with β-lactams (third generation injectable cephalosporin or
             amoxicillin-clavulanate)

          -  able to take oral medication.

          -  has given its informed consent.

        Exclusion Criteria:

          -  Creatinin &lt; 30ml/min

          -  History of jaundice / hepatic impairment associated with amoxicillin / clavulanic acid

          -  History of hypersensitivity to beta-lactam

          -  Presence of complications or severity of pneumonia (abscess , significant pleural
             effusion, severe chronic respiratory failure , septic shock, respiratory condition
             requiring the passage resuscitation).

          -  Known immunocompromised terrain ( asplenia , neutropenia, agammaglobulinemia ,
             immunosuppressants, graft corticosteroids , myeloma , lymphoma, known HIV , sickle
             cell anemia , CHILD C cirrhosis).

          -  Antibiotic treatment exceeding 24 hours prior admission.

          -  Suspected atypical bacteria requiring combined antibiotics therapy .(Subjects who
             received a single dose of macrolides or fluoroquinolones emergency will not be
             excluded) .

          -  Legionella suspected on clinical, biological and radiological criteria .

          -  Subjects with clinical or epidemiological environment leading to suspect a
             healthcare-associated pneumonia with antibiotic resistant pathogen.

          -  Suspicion of pneumonia by aspiration.

          -  Intercurrent infection requiring antibiotic treatment.

          -  Pregnant women .

          -  Breastfeeding .

          -  Allergy to antibiotics in use.

          -  Life expectancy &lt;1 month .

          -  Subject without health insurance.

          -  Subjects without home adress
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Claude CREMIEUX, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital Raymon Poincaré</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie Christine DOMBRET, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Bichat</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthieu GROH, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Cochin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth ROUVEIX, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Ambroise Paré</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pascale LONGUET, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Argenteuil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel BENHAMOU, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sylvain DIAMANTIS, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Melun Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Emmanuel Kahn, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foch Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-François BOITIAUX, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontoise Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Pierre BEDOS, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital of Versailles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jêrome PACANOWSKI, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Saint Antoine (Paris)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valérie GARRAIT, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI Creteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena FOIS, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Saint Denis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benjamin WYPLOSZ, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Bicêtre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Véronique DELCEY, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Lariboisière</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilles PIALOUX, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Tenon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthieu REVEST, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes Pontchaillou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean Paul STAHL, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Virginie VITRAT, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Annecy Genevois</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Victoire De Lastours, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Beaujon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Claude CREMIEUX, PH</last_name>
    <phone>0033147107730</phone>
    <email>anne-claude.cremieux@rpc.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélien DINH, Dr</last_name>
    <email>aurelien.dinh@rpc.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Argenteuil</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Ambroise Paré</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Aurelien DINH, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Victoire De Lastours, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Creteil</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Valerie GARRAIT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Hospital Raymon Poincaré</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Benjamin DAVIDO, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Paul STAHL, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Bicêtre</name>
      <address>
        <city>Le Kremlin Bicètre</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Benjamin WIPLOSZ, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Melun Hospital</name>
      <address>
        <city>Melun</city>
        <zip>77000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sylvain DIAMANTIS, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Annecy Genevois</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Véronique DELCEY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CH Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gilles Pialoux, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Pontoise</name>
      <address>
        <city>Pontoise</city>
        <zip>95300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Rennes Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Daniel BENHAMOU, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Saint Denis</name>
      <address>
        <city>Saint Denis</city>
        <zip>93205</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Emmanuel Kahn, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2013</study_first_submitted>
  <study_first_submitted_qc>October 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2013</study_first_posted>
  <last_update_submitted>August 11, 2017</last_update_submitted>
  <last_update_submitted_qc>August 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Anne-claude Cremieux</investigator_full_name>
    <investigator_title>Clinical Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Lactams</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

